31st Mar 2008 17:00
AstraZeneca PLC31 March 2008 Transaction by Persons Discharging Managerial Responsibilities Disclosure Rules DTR 3.1.4R We hereby inform you that on 28 March 2008 the following Directors ofAstraZeneca PLC were granted options under the AstraZeneca Share Option Planover the Company's USD0.25 Ordinary Shares. Number of shares over Exercise Total number which option price per Period when of sharesName of Director is granted share exercisable under option D R Brennan 193,856 1882p 28.3.11-27.3.18 See below S Lowth 70,138 1882p 28.3.11-27.3.18 88,803 J S Patterson 68,862 1882p 28.3.11-27.3.18 305,396 The options will become exercisable on 28 March 2011 subject to certainperformance conditions. The conditions, which will not be subject to anyretesting, are that the earnings per share of the Company must increase by theincrease in the UK Retail Prices Index plus 5% per annum on average over threeyears, and that no significant unforeseen event has taken place which, in thereasonable opinion of the Remuneration Committee, has resulted in majorreputational damage to AstraZeneca, and the circumstances of which areexceptional enough to justify the option not vesting and becoming exercisable.Failure to satisfy either or both of these conditions will result in the lapseof the option in its entirety. David R Brennan, a Director of the Company, has previously received grants ofoptions over the Company's American Depositary Shares (ADSs). One ADS equalsone Ordinary Share. Following the grant of options referred to above, DavidBrennan has options over 432,959 Ordinary Shares and 355,246 ADSs. G H R MuskerCompany Secretary31 March 2008 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Astrazeneca